Recombinant Ricin Toxin A Chain Cytotoxicity Against Carcinoembryonic Antigen Expressing Tumour Cells Mediated by a Bispecific Monoclonal Antibody and Its Potentiation by Ricin Toxin B Chain

Overview

Journal Br J Cancer

Specialty Oncology

Date 1991 May 1

PMID 2039690

Citations 8

Authors

M J Embleton

A Charleston

R A Robins

M V Pimm

R W Baldwin

Affiliations

Soon will be listed here.

Abstract

A bispecific monoclonal antibody recognising both carcinoembryonic antigen (CEA) and ricin toxin A chain (RTA) was tested for its ability to target recombinant RTA (r-RTA) to CEA-expressing tumour cells, alone and in combination with ricin B chain (RTB). The antibody, 636 (Robins et al., 1990), induced significant RTA cytotoxicity against MKN45 gastric carcinoma cells which express high levels of CEA, using the r-RTA at a concentration below that known to be intrinsically cytotoxic. The addition of ricin toxin B chain (RTB) also potentiated cytotoxicity of r-RTA, and there was an additive increase in potentiation against CEA-positive cells when both RTB and 636 were included. The bispecific antibody restored potentiation by RTB after blocking of its binding site with excess galactose, and also the cytotoxic activity of whole ricin which had been blocked with galactose. It was concluded that the 636 bispecific antibody was highly effective in targeting the toxic moiety of the molecule to CEA-expressing cells, and allowed exploitation of the additional ability of the B chain to facilitate cellular incorporation. The facilitating function of the B chain was equally effective whether or not its lectin site was active.

Citing Articles

Drugs as Chemical Weapons: Past and Perspectives.

Pitschmann V, Hon Z Toxics. 2023; 11(1).

PMID: 36668778 PMC: 9866636. DOI: 10.3390/toxics11010052.

Targeting Macromolecules to CNS and Other Hard-to-Treat Organs Using Lectin-Mediated Delivery.

Acosta W, Cramer C Int J Mol Sci. 2020; 21(3).

PMID: 32024082 PMC: 7037663. DOI: 10.3390/ijms21030971.

Augmenting the Efficacy of Immunotoxins and Other Targeted Protein Toxins by Endosomal Escape Enhancers.

Fuchs H, Weng A, Gilabert-Oriol R Toxins (Basel). 2016; 8(7).

PMID: 27376327 PMC: 4963833. DOI: 10.3390/toxins8070200.

Military Importance of Natural Toxins and Their Analogs.

Pitschmann V, Hon Z Molecules. 2016; 21(5).

PMID: 27136512 PMC: 6273326. DOI: 10.3390/molecules21050556.

Carcinoembryonic antigen antibody inhibits lung metastasis and augments chemotherapy in a human colonic carcinoma xenograft.

Blumenthal R, Osorio L, Hayes M, Horak I, Hansen H, Goldenberg D Cancer Immunol Immunother. 2004; 54(4):315-27.

PMID: 15592930 PMC: 11032782. DOI: 10.1007/s00262-004-0597-6.

References

Webb K, Liberman S, Ware J, Walther P . In vitro synergism between hybrid immunotoxins and chemotherapeutic drugs: relevance to immunotherapy of prostate carcinoma. Cancer Immunol Immunother. 1986; 21(2):100-6. PMC: 11038872. DOI: 10.1007/BF00199856. View

Wileman T, Harding C, Stahl P . Receptor-mediated endocytosis. Biochem J. 1985; 232(1):1-14. PMC: 1152830. DOI: 10.1042/bj2320001. View

Corvalan J, Smith W . Construction and characterisation of a hybrid-hybrid monoclonal antibody recognising both carcinoembryonic antigen (CEA) and vinca alkaloids. Cancer Immunol Immunother. 1987; 24(2):127-32. PMC: 11038046. DOI: 10.1007/BF00205589. View

Gregg E, Bridges S, Youle R, Longo D, Houston L, Glennie M . Whole ricin and recombinant ricin A chain idiotype-specific immunotoxins for therapy of the guinea pig L2C B cell leukemia. J Immunol. 1987; 138(12):4502-8. View

Price M, Edwards S, Jacobs E, Pawluczyk I, Byers V, Baldwin R . Mapping of monoclonal antibody-defined epitopes associated with carcinoembryonic antigen, CEA. Cancer Immunol Immunother. 1987; 25(1):10-5. PMC: 11038482. DOI: 10.1007/BF00199295. View

Cattel L, Delprino L, Brusa P, Dosio F, Comoglio P, Prat M . Comparison of blocked and non-blocked ricin-antibody immunotoxins against human gastric carcinoma and colorectal adenocarcinoma cell lines. Cancer Immunol Immunother. 1988; 27(3):233-40. PMC: 11038040. DOI: 10.1007/BF00205445. View

Glennie M, Brennand D, Bryden F, McBride H, Stirpe F, Worth A . Bispecific F(ab' gamma)2 antibody for the delivery of saporin in the treatment of lymphoma. J Immunol. 1988; 141(10):3662-70. View

Fitzgerald D, Pastan I . Targeted toxin therapy for the treatment of cancer. J Natl Cancer Inst. 1989; 81(19):1455-63. DOI: 10.1093/jnci/81.19.1455. View

Pimm M, Robins R, Embleton M, Jacobs E, Markham A, Charleston A . A bispecific monoclonal antibody against methotrexate and a human tumour associated antigen augments cytotoxicity of methotrexate-carrier conjugate. Br J Cancer. 1990; 61(4):508-13. PMC: 1971384. DOI: 10.1038/bjc.1990.115. View

10.

Byers V, Pimm M, Pawluczyk I, Lee H, Scannon P, Baldwin R . Biodistribution of ricin toxin A chain-monoclonal antibody 791T/36 immunotoxin and influence of hepatic blocking agents. Cancer Res. 1987; 47(20):5277-83. View

11.

Byers V, Pawluczyk I, Pawlucyzk I, Berry N, Durrant L, Robins R . Potentiation of anti-carcinoembryonic antigen immunotoxin cytotoxicity by monoclonal antibodies reacting with co-expressed carcinoembryonic antigen epitopes. J Immunol. 1988; 140(11):4050-5. View

12.

Eiklid K, Olsnes S, Pihl A . Entry of lethal doses of abrin, ricin and modeccin into the cytosol of HeLa cells. Exp Cell Res. 1980; 126(2):321-6. DOI: 10.1016/0014-4827(80)90270-0. View

13.

Raso V, Griffin T . Hybrid antibodies with dual specificity for the delivery of ricin to immunoglobulin-bearing target cells. Cancer Res. 1981; 41(6):2073-8. View

14.

Thorpe P, Ross W . The preparation and cytotoxic properties of antibody-toxin conjugates. Immunol Rev. 1982; 62:119-58. DOI: 10.1111/j.1600-065x.1982.tb00392.x. View

15.

Sandvig K, Olsnes S . Entry of the toxic proteins abrin, modeccin, ricin, and diphtheria toxin into cells. II. Effect of pH, metabolic inhibitors, and ionophores and evidence for toxin penetration from endocytotic vesicles. J Biol Chem. 1982; 257(13):7504-13. View

16.

Vitetta E, Cushley W, UHR J . Synergy of ricin A chain-containing immunotoxins and ricin B chain-containing immunotoxins in in vitro killing of neoplastic human B cells. Proc Natl Acad Sci U S A. 1983; 80(20):6332-5. PMC: 394291. DOI: 10.1073/pnas.80.20.6332. View

17.

Vitetta E, Fulton R, UHR J . Cytotoxicity of a cell-reactive immunotoxin containing ricin A chain is potentiated by an anti-immunotoxin containing ricin B chain. J Exp Med. 1984; 160(1):341-6. PMC: 2187422. DOI: 10.1084/jem.160.1.341. View

18.

Thorpe P, Detre S, Foxwell B, Brown A, Skilleter D, Wilson G . Modification of the carbohydrate in ricin with metaperiodate-cyanoborohydride mixtures. Effects on toxicity and in vivo distribution. Eur J Biochem. 1985; 147(1):197-206. DOI: 10.1111/j.1432-1033.1985.tb08737.x. View

19.

Webb K, Ware J, Parks S, Walther P, Paulson D . Evidence for a novel hybrid immunotoxin recognizing ricin A-chain by one antigen-combining site and a prostate-restricted antigen by the remaining antigen-combining site: potential for immunotherapy. Cancer Treat Rep. 1985; 69(6):663-72. View

20.

SIMMONS B, Stahl P, Russell J . Mannose receptor-mediated uptake of ricin toxin and ricin A chain by macrophages. Multiple intracellular pathways for a chain translocation. J Biol Chem. 1986; 261(17):7912-20. View